论文部分内容阅读
探讨米非司酮米索前列醇联合水囊及米索前列醇在中期妊娠引产中的临床效果及安全性。方法:将150例身体健康自愿要求引产的初产妇、瘢痕子宫中期妊娠妇女分为A、B两组,各75例分别给予组A:非司酮米索前列醇联合水囊及米索前列醇B组:依沙吖啶联合米非司酮引产。结果:两组在引产疼痛时间、疼痛强度、引产成功率、疼痛程度有统计学意义。结论:米非司酮联合水囊及米索前列醇终止中期妊娠,尤其是羊水过少、孕周过小的中期引产,优于依沙吖啶配联合非司酮。
To investigate the clinical efficacy and safety of mifepristone misoprostol combined with balloon and misoprostol in induction of labor in the second trimester of pregnancy. Methods: 150 cases of primiparous and scar-bearing uterus interim pregnant women were randomly divided into A and B groups, 75 cases in each group were given group A: nifedipine misoprostol combined with water balloon and misoprostol Group B: Ethacridine combined with mifepristone induced labor. Results: The pain relief time, pain intensity, success rate of induced labor and the degree of pain in two groups were statistically significant. CONCLUSION: Mifepristone combined with water balloon and misoprostol will stop the middle-term pregnancy, especially the oligohydramnios and mid-term induced labor with small gestational age, which is superior to that of ethacridine and co-administration of nifepristone.